XML 61 R50.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONDENSED CONSOLIDATING FINANCIAL STATEMENTS OF PBF HOLDINGS (Statement of Cash Flows) (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities:    
Net income $ (98,428) $ 135,256
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization 56,532 48,282
Stock-based compensation 2,621 2,025
Change in fair value of catalyst lease obligations 2,885 (2,039)
Non-cash change in inventory repurchase obligations 35,147 66,509
Gain on sale of assets 0 (359)
Pension and other post retirement benefit costs 7,680 6,448
Equity in earnings of subsidiaries 0 0
Changes in current assets and current liabilities:    
Accounts receivable (86,765) 110,084
Inventories 4,035 (1,007)
Prepaid expense and other current assets (28,142) (6,085)
Accounts payable 72,966 (22,194)
Accrued expenses 18,167 (197,427)
Deferred revenue (889) 4,859
Amounts due to/from related parties (746) (2,621)
Other assets and liabilities (2,200) (2,279)
Net cash (used in) provided by operations (43,221) 123,486
Deferred Income Tax Expense (Benefit) 31,487 0
Cash flows from investing activities:    
Expenditures for property, plant and equipment (42,731) (100,747)
Expenditures for deferred turnaround costs (82,747) (18,376)
Expenditures for other assets (17,163) (4,958)
Investment in subsidiary   0
Proceeds from sale of assets 0 77,618
Chalmette Acquisition working capital settlement (2,659) 0
Net cash used in investing activities (145,300) (46,463)
Proceeds from members' capital contributions   0
Cash flows from financing activities:    
Proceeds from Issuance of Other Long-term Debt   23,425
Distribution to members (30,829) 0
Proceeds from affiliate notes payable 0 30,000
Repayment of affiliate notes payable (517) 0
Proceeds from Rail Facility revolver borrowings 0 23,425
Payment of contingent consideration related to acquisition of Toledo refinery 0 22,774
Repayments of revolver borrowings   (22,774)
Deferred financing costs and other 0 759
Net cash (used in) provided by financing activities (31,346) 31,410
Net (decrease) increase in cash and cash equivalents (219,867) 108,433
Cash and equivalents, beginning of period 914,749 218,403
Cash and equivalents, end of period 694,882 326,836
Change in non-cash lower of cost or market inventory adjustment (59,063) (21,208)
Issuer [Member]    
Cash flows from operating activities:    
Net income (98,428) 135,256
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization 3,884 4,823
Stock-based compensation 0 0
Change in fair value of catalyst lease obligations 0 0
Non-cash change in inventory repurchase obligations 0 0
Gain on sale of assets   (182)
Pension and other post retirement benefit costs 1,732 2,079
Equity in earnings of subsidiaries 392,593 318,138
Changes in current assets and current liabilities:    
Accounts receivable (97,973) 103,083
Inventories 55,526 87,991
Prepaid expense and other current assets (6,227) (7,284)
Accounts payable 35,441 3,449
Accrued expenses (119) (179,401)
Deferred revenue (889) 4,859
Amounts due to/from related parties 412,569 273,044
Other assets and liabilities (41) 320
Net cash (used in) provided by operations (205,229) 100,355
Deferred Income Tax Expense (Benefit) 0  
Cash flows from investing activities:    
Expenditures for property, plant and equipment (5,466) (67,355)
Expenditures for deferred turnaround costs 0 0
Expenditures for other assets 0 0
Investment in subsidiary   10,000
Proceeds from sale of assets   41,597
Chalmette Acquisition working capital settlement 0  
Net cash used in investing activities (5,466) (15,758)
Proceeds from members' capital contributions   0
Cash flows from financing activities:    
Proceeds from Issuance of Other Long-term Debt   0
Distribution to members (30,829)  
Proceeds from affiliate notes payable   30,000
Repayment of affiliate notes payable (517)  
Repayments of revolver borrowings   0
Deferred financing costs and other   759
Net cash (used in) provided by financing activities (31,346) 30,759
Net (decrease) increase in cash and cash equivalents (242,041) 115,356
Cash and equivalents, beginning of period 882,820 185,381
Cash and equivalents, end of period 640,779 300,737
Change in non-cash lower of cost or market inventory adjustment (78,159) (99,732)
Guarantors Subsidiaries [Member]    
Cash flows from operating activities:    
Net income (369,221) (358,666)
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization 50,700 42,789
Stock-based compensation 2,621 2,025
Change in fair value of catalyst lease obligations 2,885 (2,039)
Non-cash change in inventory repurchase obligations 35,147 66,509
Gain on sale of assets   0
Pension and other post retirement benefit costs 5,948 4,369
Equity in earnings of subsidiaries 0 0
Changes in current assets and current liabilities:    
Accounts receivable 6,717 14,653
Inventories (28,387) (59,790)
Prepaid expense and other current assets (22,016) 1,199
Accounts payable 37,120 (21,672)
Accrued expenses (3,661) 19,491
Deferred revenue 0 0
Amounts due to/from related parties (416,735) (271,231)
Other assets and liabilities (3,511) (2,601)
Net cash (used in) provided by operations 150,173 56,022
Deferred Income Tax Expense (Benefit) 0  
Cash flows from investing activities:    
Expenditures for property, plant and equipment (37,260) (33,392)
Expenditures for deferred turnaround costs (82,747) (18,376)
Expenditures for other assets (17,163) (4,958)
Investment in subsidiary   0
Proceeds from sale of assets   0
Chalmette Acquisition working capital settlement (2,659)  
Net cash used in investing activities (139,829) (56,726)
Proceeds from members' capital contributions   0
Cash flows from financing activities:    
Proceeds from Issuance of Other Long-term Debt   0
Distribution to members 0  
Proceeds from affiliate notes payable   0
Repayment of affiliate notes payable 0  
Repayments of revolver borrowings   0
Deferred financing costs and other   0
Net cash (used in) provided by financing activities 0 0
Net (decrease) increase in cash and cash equivalents 10,344 (704)
Cash and equivalents, beginning of period 6,236 704
Cash and equivalents, end of period 16,580 0
Change in non-cash lower of cost or market inventory adjustment 19,096 78,524
Non-Guarantor Subsidiaries [Member]    
Cash flows from operating activities:    
Net income (23,372) 40,528
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization 1,948 670
Stock-based compensation 0 0
Change in fair value of catalyst lease obligations 0 0
Non-cash change in inventory repurchase obligations 0 0
Gain on sale of assets   (177)
Pension and other post retirement benefit costs 0 0
Equity in earnings of subsidiaries 0 0
Changes in current assets and current liabilities:    
Accounts receivable 4,491 (7,652)
Inventories (23,104) (29,208)
Prepaid expense and other current assets 101 0
Accounts payable (577) (4,834)
Accrued expenses 21,947 (37,517)
Deferred revenue 0 0
Amounts due to/from related parties 3,420 (4,434)
Other assets and liabilities 1,352 2
Net cash (used in) provided by operations 10,853 (33,754)
Deferred Income Tax Expense (Benefit) 31,487  
Cash flows from investing activities:    
Expenditures for property, plant and equipment (5) 0
Expenditures for deferred turnaround costs 0 0
Expenditures for other assets 0 0
Investment in subsidiary   0
Proceeds from sale of assets   36,021
Chalmette Acquisition working capital settlement 0  
Net cash used in investing activities (5) 36,021
Proceeds from members' capital contributions   (10,000)
Cash flows from financing activities:    
Proceeds from Issuance of Other Long-term Debt   23,425
Distribution to members 0  
Proceeds from affiliate notes payable   0
Repayment of affiliate notes payable 0  
Repayments of revolver borrowings   (22,774)
Deferred financing costs and other   0
Net cash (used in) provided by financing activities 0 (9,349)
Net (decrease) increase in cash and cash equivalents 10,848 (7,082)
Cash and equivalents, beginning of period 28,968 34,334
Cash and equivalents, end of period 39,816 27,252
Change in non-cash lower of cost or market inventory adjustment 0 0
Combining and Consolidated Adjustments [Member]    
Cash flows from operating activities:    
Net income 392,593 318,138
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization 0 0
Stock-based compensation 0 0
Change in fair value of catalyst lease obligations 0 0
Non-cash change in inventory repurchase obligations 0 0
Gain on sale of assets   0
Pension and other post retirement benefit costs 0 0
Equity in earnings of subsidiaries (392,593) (318,138)
Changes in current assets and current liabilities:    
Accounts receivable 0 0
Inventories 0 0
Prepaid expense and other current assets 0 0
Accounts payable 982 863
Accrued expenses 0 0
Deferred revenue 0 0
Amounts due to/from related parties 0 0
Other assets and liabilities 0 0
Net cash (used in) provided by operations 982 863
Deferred Income Tax Expense (Benefit) 0  
Cash flows from investing activities:    
Expenditures for property, plant and equipment 0 0
Expenditures for deferred turnaround costs 0 0
Expenditures for other assets 0 0
Investment in subsidiary   (10,000)
Proceeds from sale of assets   0
Chalmette Acquisition working capital settlement 0  
Net cash used in investing activities 0 (10,000)
Proceeds from members' capital contributions   10,000
Cash flows from financing activities:    
Proceeds from Issuance of Other Long-term Debt   0
Distribution to members 0  
Proceeds from affiliate notes payable   0
Repayment of affiliate notes payable 0  
Repayments of revolver borrowings   0
Deferred financing costs and other   0
Net cash (used in) provided by financing activities 0 10,000
Net (decrease) increase in cash and cash equivalents 982 863
Cash and equivalents, beginning of period (3,275) (2,016)
Cash and equivalents, end of period (2,293) (1,153)
Change in non-cash lower of cost or market inventory adjustment $ 0 $ 0